Vector Control Advisory Group
Independent evaluation of the public health value of innovative new tools, technologies and approaches for vector control is needed to enable WHO to provide evidence-based advice to Member States on whether their deployment is justified. This is essential to ensure that scarce resources available for disease control are used to maximum impact. In order to assist WHO in developing public health policy on new tools, the Vector Control Advisory Group (VCAG) assesses the public health value of new interventions and provides guidance on developing the evidence base required to inform such assessments.
The next meeting will take place on 8–10 June 2020
VCAG is jointly managed by the Global Malaria Programme, the Department of Control of Neglected Tropical Diseases, and the WHO Prequalification Team for vector control products.
- To provide guidance to product developers, innovators and researchers, through WHO, on the generation of epidemiological data and study designs to enable assessment of the public health value of new vector control interventions;
- To assess the public health value of new vector interventions submitted to WHO;
- To provide advice to WHO, for submission to the Malaria Policy Advisory Committee (MPAC) and the Strategic and Technical Advisory Group for neglected tropical diseases (STAG), on the public health value of new interventions.